Jundishapur Journal of Microbiology

Published by: Kowsar

Moderate Genetic Diversity with Extensive Antimicrobial Resistance Among Multidrug-Resistant Acinetobacter baumannii in a Referral Hospital in Northeast Iran

Arman Mosavat 1 , Saman Soleimanpour 2 , 3 , Hadi Farsiani 2 , 3 , Himen Salimizand 4 , Abdollah Kebriaei 5 , Saeid Amel Jamehdar 2 , 3 , Mahmoud Bagheri 2 , 3 , Seyed Abdolrahim Rezaee 6 and Kiarash Ghazvini 2 , 3 , *
Authors Information
1 Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan, Mashhad, IR Iran
2 Antimicrobial Resistance Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
5 Department of Microbiology and Virology, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnord, IR Iran
6 Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: July 2018, 11 (7); e14412
  • Published Online: July 10, 2018
  • Article Type: Research Article
  • Received: June 1, 2017
  • Revised: May 27, 2018
  • Accepted: May 29, 2018
  • DOI: 10.5812/jjm.14412

To Cite: Mosavat A, Soleimanpour S, Farsiani H, Salimizand H, Kebriaei A, et al. Moderate Genetic Diversity with Extensive Antimicrobial Resistance Among Multidrug-Resistant Acinetobacter baumannii in a Referral Hospital in Northeast Iran, Jundishapur J Microbiol. 2018 ; 11(7):e14412. doi: 10.5812/jjm.14412.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
Footnotes
References
  • 1. Kilic A, Li H, Mellmann A, Basustaoglu AC, Kul M, Senses Z, et al. Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J Clin Microbiol. 2008;46(3):902-8. doi: 10.1128/JCM.01876-07. [PubMed: 18160455]. [PubMed Central: PMC2268383].
  • 2. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73(4):355-63. doi: 10.1016/j.jhin.2009.03.032. [PubMed: 19700220].
  • 3. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939-51. doi: 10.1038/nrmicro1789. [PubMed: 18007677].
  • 4. Alvargonzalez JJ, Vindel Hernando A, Martin MD, Casas CM, Iglesias JO, Marin MF, et al. Sequential outbreaks in a Spanish hospital caused by multiresistant OXA-58-producing Acinetobacter baumannii ST92. J Med Microbiol. 2014;63(Pt 8):1093-8. doi: 10.1099/jmm.0.067280-0. [PubMed: 24866368].
  • 5. Farsiani H, Mosavat A, Soleimanpour S, Nasab MN, Salimizand H, Jamehdar SA, et al. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. J Med Microbiol. 2015;64(7):767-73. doi: 10.1099/jmm.0.000090. [PubMed: 25991693].
  • 6. Jones CL, Clancy M, Honnold C, Singh S, Snesrud E, Onmus-Leone F, et al. Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. Clin Infect Dis. 2015;61(2):145-54. doi: 10.1093/cid/civ225. [PubMed: 25824815].
  • 7. Merino M, Poza M, Roca I, Barba MJ, Sousa MD, Vila J, et al. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb Drug Resist. 2014;20(4):259-63. doi: 10.1089/mdr.2013.0127. [PubMed: 24328852].
  • 8. Salimizand H, Noori N, Meshkat Z, Ghazvini K, Amel SJ. Prevalence of Acinetobacter baumannii harboring ISAba1/bla OXA-23-like family in a burn center. Burns. 2015;41(5):1100-6. doi: 10.1016/j.burns.2014.12.008. [PubMed: 25603980].
  • 9. Sarhaddi N, Soleimanpour S, Farsiani H, Mosavat A, Dolatabadi S, Salimizand H, et al. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran. J Glob Antimicrob Resist. 2017;8:60-6. doi: 10.1016/j.jgar.2016.10.009. [PubMed: 28011349].
  • 10. Apisarnthanarak A, Khawcharoenporn T, Mundy LM. Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey. Am J Infect Control. 2013;41(5):416-21. doi: 10.1016/j.ajic.2012.05.011. [PubMed: 23098775].
  • 11. Kraniotaki E, Manganelli R, Platsouka E, Grossato A, Paniara O, Palu G. Molecular investigation of an outbreak of multidrug-resistant Acinetobacter baumannii, with characterisation of class 1 integrons. Int J Antimicrob Agents. 2006;28(3):193-9. doi: 10.1016/j.ijantimicag.2006.04.016. [PubMed: 16904293].
  • 12. Heritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect. 2006;12(2):123-30. doi: 10.1111/j.1469-0691.2005.01320.x. [PubMed: 16441449].
  • 13. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006;258(1):72-7. doi: 10.1111/j.1574-6968.2006.00195.x. [PubMed: 16630258].
  • 14. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-82. doi: 10.1128/CMR.00058-07. [PubMed: 18625687]. [PubMed Central: PMC2493088].
  • 15. Alaei N, Aziemzadeh M, Bahador A. Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran. J Glob Antimicrob Resist. 2016;5:75-9. doi: 10.1016/j.jgar.2015.12.005. [PubMed: 27436472].
  • 16. Anvarinejad M, Japoni A, Davarpanah MA, Mahmudi H, Mammina C, Vazin A. Phenotypic and Molecular Epidemiology of Acinetobacter calcoaceticus baumannii Complex Strains Spread at Nemazee Hospital of Shiraz, Iran. Jundishapur J Microbiol. 2015;8(6). e19180. doi: 10.5812/jjm.8(5)2015.19180. [PubMed: 26322204]. [PubMed Central: PMC4548468].
  • 17. Bagheri Josheghani S, Moniri R, Firoozeh F, Sehat M, Dasteh Goli Y. Susceptibility Pattern and Distribution of Oxacillinases and bla PER-1 Genes among Multidrug Resistant Acinetobacter baumannii in a Teaching Hospital in Iran. J Pathog. 2015;2015:957259. doi: 10.1155/2015/957259. [PubMed: 26881082]. [PubMed Central: PMC4736200].
  • 18. Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A, Mammina C. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J Antimicrob Chemother. 2014;69(9):2383-7. doi: 10.1093/jac/dku045. [PubMed: 24562615].
  • 19. Japoni-Nejad A, Sofian M, Belkum AV, Ghaznavi-Rad E. Nosocomial Outbreak of Extensively and Pan Drug-Resistant Acinetobacter baumannii in Tertiary Hospital in Central Part of Iran. Jundishapur Journal of Microbiology. 2013;6(8). doi: 10.5812/jjm.9892.
  • 20. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. Washington DC: American Society for Microbiology; 2006.
  • 21. Higgins PG, Wisplinghoff H, Krut O, Seifert H. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect. 2007;13(12):1199-201. doi: 10.1111/j.1469-0691.2007.01819.x. [PubMed: 17850345].
  • 22. Wayne P. Performance standards for antimicrobial disk diffusion susceptibility tests. CLSI. 2009;29(2009).
  • 23. Yan ZQ, Shen DX, Cao JR, Chen R, Wei X, Liu LP, et al. Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China. Int J Antimicrob Agents. 2010;35(3):269-73. doi: 10.1016/j.ijantimicag.2009.10.016. [PubMed: 20036519].
  • 24. Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltran J. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect. 2000;6(12):635-43. [PubMed: 11284921].
  • 25. Heras J, Dominguez C, Mata E, Pascual V, Lozano C, Torres C, et al. GelJ--a tool for analyzing DNA fingerprint gel images. BMC Bioinformatics. 2015;16:270. doi: 10.1186/s12859-015-0703-0. [PubMed: 26307353]. [PubMed Central: PMC4549892].
  • 26. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 2007;13(8):807-15. doi: 10.1111/j.1469-0691.2007.01759.x. [PubMed: 17610600].
  • 27. Segal H, Garny S, Elisha BG. Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol Lett. 2005;243(2):425-9. doi: 10.1016/j.femsle.2005.01.005. [PubMed: 15686845].
  • 28. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53(Pt 12):1233-40. doi: 10.1099/jmm.0.45716-0. [PubMed: 15585503].
  • 29. Srinivasan VB, Rajamohan G, Pancholi P, Stevenson K, Tadesse D, Patchanee P, et al. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbiol Antimicrob. 2009;8:21. doi: 10.1186/1476-0711-8-21. [PubMed: 19531268]. [PubMed Central: PMC2705342].
  • 30. Noppe-Leclercq I, Wallet F, Haentjens S, Courcol R, Simonet M. PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res Microbiol. 1999;150(5):317-22. [PubMed: 10422692].
  • 31. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50(12):4114-23. doi: 10.1128/AAC.00778-06. [PubMed: 17000742]. [PubMed Central: PMC1694013].
  • 32. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351-3. doi: 10.1016/j.ijantimicag.2006.01.004. [PubMed: 16564159].
  • 33. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59(2):321-2. doi: 10.1093/jac/dkl481. [PubMed: 17185300].
  • 34. Park YK, Lee GH, Baek JY, Chung DR, Peck KR, Song JH, et al. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea. Microb Drug Resist. 2010;16(2):143-9. doi: 10.1089/mdr.2009.0088. [PubMed: 20370437].
  • 35. Munoz-Price LS. Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey. J Hosp Infect. 2015;89(4):254-8. doi: 10.1016/j.jhin.2015.02.006. [PubMed: 25766464].
  • 36. Nigro SJ, Hall RM. Amikacin resistance plasmids in extensively antibiotic-resistant GC2 Acinetobacter baumannii from two Australian hospitals. J Antimicrob Chemother. 2014;69(12):3435-7. doi: 10.1093/jac/dku310. [PubMed: 25103493].
  • 37. Kamolvit W, Sidjabat HE, Paterson DL. Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania. Microb Drug Resist. 2015;21(4):424-34. doi: 10.1089/mdr.2014.0234. [PubMed: 25714653].
  • 38. Shoja S, Moosavian M, Peymani A, Tabatabaiefar MA, Rostami S, Ebrahimi N. Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran. Iran J Microbiol. 2013;5(4):315-22. [PubMed: 25848498]. [PubMed Central: PMC4385154].
  • 39. Hakemi Vala M, Hallajzadeh M, Hashemi A, Goudarzi H, Tarhani M, Sattarzadeh Tabrizi M, et al. Detection of Ambler class A, B and D ss-lactamases among Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from burn patients. Ann Burns Fire Disasters. 2014;27(1):8-13. [PubMed: 25249841]. [PubMed Central: PMC4150481].
  • 40. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68-74. [PubMed: 22347585]. [PubMed Central: PMC3279807].
  • 41. Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, et al. Prevalence of OXA-type beta-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 2012;18(4):385-9. doi: 10.1089/mdr.2011.0077. [PubMed: 22352411].
  • 42. Aghazadeh M, Rezaee MA, Nahaei MR, Mahdian R, Pajand O, Saffari F, et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist. 2013;19(4):282-8. doi: 10.1089/mdr.2012.0223. [PubMed: 23577624].
  • 43. Aliakbarzade K, Farajnia S, Karimi Nik A, Zarei F, Tanomand A. Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates. Jundishapur J Microbiol. 2014;7(10). e11924. doi: 10.5812/jjm.11924. [PubMed: 25632323]. [PubMed Central: PMC4295313].
  • 44. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns. 2012;38(8):1198-203. doi: 10.1016/j.burns.2012.04.008. [PubMed: 22579564].
  • 45. Rumbo C, Gato E, Lopez M, Ruiz de Alegria C, Fernandez-Cuenca F, Martinez-Martinez L, et al. Contribution of efflux pumps, porins, and beta-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57(11):5247-57. doi: 10.1128/AAC.00730-13. [PubMed: 23939894]. [PubMed Central: PMC3811325].
  • 46. Yoon EJ, Courvalin P, Grillot-Courvalin C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother. 2013;57(7):2989-95. doi: 10.1128/AAC.02556-12. [PubMed: 23587960]. [PubMed Central: PMC3697384].
  • 47. Huys G, Cnockaert M, Vaneechoutte M, Woodford N, Nemec A, Dijkshoorn L, et al. Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol. 2005;156(3):348-55. doi: 10.1016/j.resmic.2004.10.008. [PubMed: 15808938].
  • 48. Maleki MH, Sekawi Z, Soroush S, Azizi-Jalilian F, Asadollahi K, Mohammadi S, et al. Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iran J Basic Med Sci. 2014;17(1):21-6. [PubMed: 24592303]. [PubMed Central: PMC3938882].
  • 49. Martin-Lozano D, Cisneros JM, Becerril B, Cuberos L, Prados T, Ortiz-Leyba C, et al. Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol. 2002;40(12):4571-5. [PubMed: 12454154]. [PubMed Central: PMC154637].
  • 50. Maiden MC. Multilocus sequence typing of bacteria. Annu Rev Microbiol. 2006;60:561-88. doi: 10.1146/annurev.micro.59.030804.121325. [PubMed: 16774461].
  • 51. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4382-90. doi: 10.1128/JCM.43.9.4382-4390.2005. [PubMed: 16145081]. [PubMed Central: PMC1234098].
  • 52. Ahmadi A, Salimizand H. Delayed identification of Acinetobacter baumannii during an outbreak owing to disrupted blaOXA-51-like by ISAba19. Int J Antimicrob Agents. 2017;50(1):119-22. doi: 10.1016/j.ijantimicag.2017.03.006. [PubMed: 28533186].
  • 53. Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D, Haghighi MA, et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol. 2015;6:1146. doi: 10.3389/fmicb.2015.01146. [PubMed: 26539176]. [PubMed Central: PMC4611150].
  • 54. Piran A, Shahcheraghi F, Solgi H, Rohani M, Badmasti F. A reliable combination method to identification and typing of epidemic and endemic clones among clinical isolates of Acinetobacter baumannii. Infect Genet Evol. 2017;54:501-7. doi: 10.1016/j.meegid.2017.08.018. [PubMed: 28827174].
  • 55. Saffari F, Monsen T, Karmostaji A, Azimabad FB, Widerstrom M. Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in southern Iran. J Med Microbiol. 2017;66(11):1656-62. doi: 10.1099/jmm.0.000619. [PubMed: 29058650].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments